HomeBIOBV • HEL
add
Biohit Oyj
Previous close
€2.22
Day range
€2.21 - €2.37
Year range
€2.20 - €3.78
Market cap
27.13M EUR
Avg Volume
11.06K
P/E ratio
-
Dividend yield
-
Primary exchange
HEL
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 4.17M | 21.05% |
Operating expense | 2.00M | 14.79% |
Net income | 919.00K | 34.36% |
Net profit margin | 22.06 | 10.97% |
Earnings per share | — | — |
EBITDA | 1.08M | 58.59% |
Effective tax rate | -2.05% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.85M | -27.71% |
Total assets | 19.81M | 27.77% |
Total liabilities | 4.87M | 47.03% |
Total equity | 14.94M | — |
Shares outstanding | 15.20M | — |
Price to book | 2.27 | — |
Return on assets | 11.69% | — |
Return on capital | 14.01% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 919.00K | 34.36% |
Cash from operations | 276.00K | -73.54% |
Cash from investing | -363.00K | -1,007.50% |
Cash from financing | -93.00K | -43.08% |
Net change in cash | -203.50K | -120.62% |
Free cash flow | 486.69K | 79.30% |
About
Biohit Oyj is a Finnish company which develops, manufactures, and markets biotech and diagnostics products for use in research and health care. Wikipedia
Founded
1988
Website
Employees
46
